Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease
Clinical trial NCT00428389 · COMPLETED
Trial details
- NCT number
- NCT00428389
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2008-02-01
- Enrollment
- 262
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.